Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer

作者: Ya-Ting Chen , Albert A. Luderer , Robert P. Thiel , Grant Carlson , Carole L. Cuny

DOI: 10.1016/S0090-4295(99)80487-7

关键词:

摘要: Abstract Objectives This study was undertaken to define the probability of prostate cancer as a function proportion free total prostate-specific antigen (FTPSA), PSA, and age for those patients with PSA levels between 2.5 20.0 ng/mL. Methods Prebiopsy serums were obtained from 428 untreated (165 malignant, 263 benign) who had undergone sextant six-core biopsy. Each patient no prior history prebiopsy value Total determined using PA immunoassay performed on TOSOH AIA-1200 automated instrument. Free monoclonal-polyclonal antibody sandwich radioimmunoassay. Results In men values ng/mL, FTPSA significantly differentiated benign malignant histologic states. Log linear modeling indicated distinct differences in risk FTPSA, age. The highest observed greater than 70 years less 7% more 10.0 Conversely, lowest 60 25% 4 Conclusions that will be found biopsy has marked gradient is associated age, FTPSA. extreme ends are diagnostic prostatic disease, respectively.

参考文章(18)
Alan W. Partin, Joseph E. Oesterling, The Clinical Usefulness of Prostate Specific Antigen: Update 1994 Journal of Urology. ,vol. 152, pp. 1358- 1368 ,(1994) , 10.1016/S0022-5347(17)32422-9
A W Partin, P C Walsh, J I Epstein, C R Pound, J Q Clemens, Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years Urologic Clinics of North America. ,vol. 20, pp. 713- 725 ,(1993) , 10.1016/S0094-0143(21)00924-1
Arthur I. Holleb, Diane J. Fink, Gerald Patrick Murphy, American Cancer Society textbook of clinical oncology The Society. ,(1991)
David W. Keetch, William J. Catalona, Deborah S. Smith, Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values The Journal of Urology. ,vol. 151, pp. 1571- 1574 ,(1994) , 10.1016/S0022-5347(17)35304-1
H Lilja, A Christensson, U Dahlén, M T Matikainen, O Nilsson, K Pettersson, T Lövgren, Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clinical Chemistry. ,vol. 37, pp. 1618- 1625 ,(1991) , 10.1093/CLINCHEM/37.9.1618
Anders christensson, Thomas Björk, Olle Nilsson, Ulrika Dahlén, Marja-Terttu Matikainen, Abraham T.K. Cockett, Per-Anders Abrahamsson, Hans Lilja, Serum Prostate Specific Antigen Complexed to α1-Antichymotrypsin as an Indicator of Prostate Cancer The Journal of Urology. ,vol. 150, pp. 100- 105 ,(1993) , 10.1016/S0022-5347(17)35408-3
D Rusciano, A Berardi, C Ceccarini, B Terrana, Concomitant purification of prostatic carcinoma tumor markers from human seminal fluid under nondenaturing conditions. Clinical Chemistry. ,vol. 34, pp. 2528- 2532 ,(1988) , 10.1093/CLINCHEM/34.12.2528
Anders CHRISTENSSON, Carl-Bertil LAURELL, Hans LILJA, Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. FEBS Journal. ,vol. 194, pp. 755- 763 ,(1990) , 10.1111/J.1432-1033.1990.TB19466.X
Albert A. Luderer, Ya-Ting Chen, Thomas F. Soriano, William J. Kramp, Grant Carlson, Carol Cuny, Thomas Sharp, William Smith, Jason Petteway, Michael K. Brawer, Robert Thiel, Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen Urology. ,vol. 46, pp. 187- 194 ,(1995) , 10.1016/S0090-4295(99)80192-7
Joseph E. Oesterling, Steven J. Jacobsen, George G. Klee, Kim Petterson, Timo Piironen, Per-Anders Abrahamsson, Ulf-Hakan Stenman, Barry Dowell, Timo Lovgren, Hans Lilja, Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and Ratios Journal of Urology. ,vol. 154, pp. 1090- 1095 ,(1995) , 10.1016/S0022-5347(01)66984-2